Sugarloaf Wealth Management, LLC Amgen Inc Transaction History

Sugarloaf Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 20, 2021	SELL	$212.27 - $248.7 $9,339 - $10,942	-44 Reduced 18.03%	200 $43,000
Q2 2021 Jul 20, 2021	BUY	$233.58 - $259.14 $10,277 - $11,402	44 Added 22.0%	244 $59,000
Q1 2020 Apr 15, 2020	SELL	$182.24 - $241.7 $6,925 - $9,184	-38 Reduced 15.97%	200 $41,000
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $45,031 - $57,881	238 New	238 $57,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Sugarloaf Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sugarloaf Wealth Management, LLC with notifications on news.